By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Medical device regulation is overseen in Qatar by the Ministry of Economy and Commerce (MEC). Medical equipment now does not need to be registered, but an import permit is required, and that permit must be obtained through a local authorised representative.
The main elements of a medical device are mechanics, motors, and motion control, all of which must be continuously improved for increased effectiveness.
The Qatari medical device market will increase with imports providing the majority of the market’s supply. The economy will grow above trend, propelled by strong net exports and private consumption.
The Qatar Medical Devices Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Qatari Germany is considering a manufacturing expansion for medical devices. QATARI: OHA According to a news release, Qatari Germany for Medical Devices Company (QGMD), a major Middle Eastern producer of medical devices, is now examining the extent of the potential for expanding the facility by adding additional manufacturing lines to be able to meet domestic and international orders.
The company has examined adding new products to its product portfolio, which will be disclosed later, in order to meet the anticipated rise in local and global demand for medical supplies. This move will improve the company’s financial results and boost sales volume.
Additionally, Qatari Germany for Medical Devices Company (QGMD) is currently completing the process of receiving accreditation for its goods from the U.S. Drug and Food Administration (FDA), where it is one of the cornerstones of plans to expand goods and facilitate adoption, which will aid in the opening of new markets.
For the first time in its history, the business was able to increase its production capacity, which inspired it to improve the standard of its industry and compete fiercely on the global markets, leading to a number of confirmed commercial transactions involving medical syringes and the opening of new markets in more than 10 nations worldwide.
As the business closes numerous business agreements for the sale of syringes to more than 8 nations, including Australia, Belgium, Britain, Germany, Iraq, South Africa, Mexico, and Chile,